• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多支冠状动脉疾病血运重建的完整性及其对一年结局的影响:美国国立心肺血液研究所动态注册研究报告

Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.

作者信息

Srinivas Vankeepuram S, Selzer Faith, Wilensky Robert L, Holmes David R, Cohen Howard A, Monrad E Scott, Jacobs Alice K, Kelsey Sheryl F, Williams David O, Kip Kevin E

机构信息

Division of Cardiology, Montefiore Medical Center, New York, NY 10461, USA.

出版信息

J Interv Cardiol. 2007 Oct;20(5):373-80. doi: 10.1111/j.1540-8183.2007.00273.x.

DOI:10.1111/j.1540-8183.2007.00273.x
PMID:17880334
Abstract

When percutaneous coronary intervention (PCI) is performed in patients with multivessel coronary disease, a targeted revascularization (TR) of diseased vessels is performed more often than complete revascularization (CR). We compared baseline characteristics and 1-year outcomes of patients undergoing TR by operator choice (n = 1,091), TR because CR was unachievable (n = 375), and CR (n = 315) in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Patients receiving TR because CR was unachievable were older, had more comorbidities, worse ejection fraction, less often received 2b/3a inhibitors and stents, and less frequently achieved complete angiographic success than either patients receiving TR by choice or CR. Despite these considerable differences, cumulative rates of 1-year mortality, the need for repeat PCI, or coronary bypass surgery were similar in patients who received CR, TR by choice, or TR because CR was unachievable. In multivariable models, after adjustment for clinical characteristics and propensity to receive CR, the hazard ratio for CR versus TR was 1.10 (95% CI: 0.58-2.10) for 1-year mortality; 0.89 (0.60-1.32) for repeat PCI, and 0.92 (0.66-1.29) for repeat PCI or coronary bypass surgery. In conclusion, despite the presence of more unfavorable characteristics, patients undergoing TR demonstrate 1-year outcomes equivalent to those having CR, supporting its continued use in selected patients.

摘要

在患有多支冠状动脉疾病的患者中进行经皮冠状动脉介入治疗(PCI)时,对病变血管进行靶向血运重建(TR)的情况比完全血运重建(CR)更为常见。我们在国立心肺血液研究所(NHLBI)动态注册研究中比较了因术者选择进行TR的患者(n = 1091)、因无法实现CR而进行TR的患者(n = 375)以及进行CR的患者(n = 315)的基线特征和1年结局。因无法实现CR而接受TR的患者年龄更大,合并症更多,射血分数更差,接受2b/3a抑制剂和支架的频率更低,与因选择进行TR或CR的患者相比,完全血管造影成功的频率更低。尽管存在这些显著差异,但接受CR、因选择进行TR或因无法实现CR而进行TR的患者1年死亡率、再次进行PCI或冠状动脉搭桥手术的累积发生率相似。在多变量模型中,在调整临床特征和接受CR的倾向后,CR与TR相比,1年死亡率的风险比为1.10(95%CI:0.58 - 2.10);再次进行PCI的风险比为0.89(0.60 - 1.32),再次进行PCI或冠状动脉搭桥手术的风险比为0.92(0.66 - 1.29)。总之,尽管存在更多不利特征,但接受TR的患者1年结局与接受CR的患者相当,这支持在特定患者中继续使用TR。

相似文献

1
Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.多支冠状动脉疾病血运重建的完整性及其对一年结局的影响:美国国立心肺血液研究所动态注册研究报告
J Interv Cardiol. 2007 Oct;20(5):373-80. doi: 10.1111/j.1540-8183.2007.00273.x.
2
Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.急性冠状动脉综合征患者单纯罪犯血管血运重建与多支血管血运重建:美国心脏病学会国家心血管数据库注册研究报告
Am Heart J. 2008 Jan;155(1):140-6. doi: 10.1016/j.ahj.2007.09.007.
3
Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.多支冠状动脉疾病且既往有冠状动脉搭桥手术史患者经皮冠状动脉介入治疗或再次冠状动脉搭桥手术的血运重建方法预测因素及长期预后
Eur Heart J. 2006 Feb;27(4):413-8. doi: 10.1093/eurheartj/ehi646. Epub 2005 Nov 4.
4
Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.多支血管药物洗脱支架置入术与糖尿病的影响——来自EVENT注册研究的报告
Catheter Cardiovasc Interv. 2009 Jun 1;73(7):874-80. doi: 10.1002/ccd.21925.
5
Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus.糖尿病患者当代经皮冠状动脉介入治疗的疗效有显著改善。
J Interv Cardiol. 2006 Dec;19(6):475-82. doi: 10.1111/j.1540-8183.2006.00211.x.
6
Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era.经皮冠状动脉介入治疗血管重建完整性对支架时代长期预后的影响。
Circulation. 2006 May 23;113(20):2406-12. doi: 10.1161/CIRCULATIONAHA.106.612267. Epub 2006 May 15.
7
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.糖尿病患者与非糖尿病患者的多支冠状动脉血运重建:ARTS-II(动脉血运重建治疗研究 - 第二部分)试验的3年随访
J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.
8
Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.与经皮冠状动脉介入治疗相比,在大多数多支冠状动脉疾病亚组患者中,外科血管重建术与更好的长期预后相关:来自山间心脏注册研究的结果。
Circulation. 2007 Sep 11;116(11 Suppl):I226-31. doi: 10.1161/CIRCULATIONAHA.106.681346.
9
Culprit only versus complete coronary revascularization during primary PCI.直接经皮冠状动脉介入治疗期间罪犯血管单独处理与完全冠状动脉血运重建的比较
Int J Cardiol. 2008 Jan 24;123(3):288-92. doi: 10.1016/j.ijcard.2006.12.013. Epub 2007 Apr 10.
10
Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.在常规临床实践中药物洗脱支架与裸金属支架的 unrestricted 使用:来自美国国立心肺血液研究所动态注册研究的结果。(注:这里“unrestricted”翻译为“无限制的”,但感觉表述不太准确,可能原文有特定含义,需结合更多背景理解)
J Am Coll Cardiol. 2007 Nov 20;50(21):2029-36. doi: 10.1016/j.jacc.2007.07.071.

引用本文的文献

1
Revascularization Strategies for Non-ST-Elevation Myocardial Infarction.非 ST 段抬高型心肌梗死的血运重建策略。
Curr Cardiol Rep. 2019 Apr 10;21(5):39. doi: 10.1007/s11886-019-1125-9.
2
Impact of Incomplete Percutaneous Revascularization in Patients With Multivessel Coronary Artery Disease: A Systematic Review and Meta-Analysis.多支冠状动脉疾病患者经皮血管重建不完全的影响:一项系统评价和荟萃分析
J Am Heart Assoc. 2016 Dec 16;5(12):e004598. doi: 10.1161/JAHA.116.004598.
3
Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.
经皮冠状动脉介入治疗后未经治疗的冠状动脉疾病的量化和影响:残余 SYNTAX(紫杉醇与心脏手术联合 PCI 的协同作用)评分。
J Am Coll Cardiol. 2012 Jun 12;59(24):2165-74. doi: 10.1016/j.jacc.2012.03.010. Epub 2012 Apr 4.
4
Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.经国家心肺血液研究所资助的多中心 1985-1986 年经皮冠状动脉介入治疗和 1997-2006 年动态登记研究二十年演变及其对临床结果的影响。
Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15.
5
Therapeutic options in coronary artery disease: focusing on the guidelines.冠状动脉疾病的治疗选择:聚焦指南
Can J Cardiol. 2009 Jan;25(1):19-24. doi: 10.1016/s0828-282x(09)70018-2.